These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21281874)

  • 1. Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children.
    Kuna P; Kaczmarek J; Kupczyk M
    J Allergy Clin Immunol; 2011 Feb; 127(2):502-508.e1-6. PubMed ID: 21281874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety.
    Tabar AI; Lizaso MT; García BE; Gómez B; Echechipía S; Aldunate MT; Madariaga B; Martínez A
    Pediatr Allergy Immunol; 2008 Feb; 19(1):67-75. PubMed ID: 17651380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sublingual specific immunotherapy in patients with respiratory allergy to Alternaria alternata: a randomised, assessor-blinded, patient-reported outcome, controlled 3-year trial.
    Pozzan M; Milani M
    Curr Med Res Opin; 2010 Dec; 26(12):2801-6. PubMed ID: 21050060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma.
    Tabar AI; Lizaso MT; García BE; Echechipía S; Olaguibel JM; Rodríguez A
    J Investig Allergol Clin Immunol; 2000; 10(6):327-33. PubMed ID: 11206932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of sublingual immunotherapy with a monomeric allergoid in very young children.
    Agostinis F; Tellarini L; Canonica GW; Falagiani P; Passalacqua G
    Allergy; 2005 Jan; 60(1):133. PubMed ID: 15575951
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children.
    Caramia G; Franceschini F; Cimarelli ZA; Ciucchi MS; Gagliardini R; Ruffini E
    Allerg Immunol (Paris); 1996 Nov; 28(9):308-10. PubMed ID: 8986246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of mold allergy: A review.
    Bozek A; Pyrkosz K
    Hum Vaccin Immunother; 2017 Oct; 13(10):2397-2401. PubMed ID: 28481693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of alternaria alternata allergy: a prospective study in 6840 Italian asthmatic children.
    Cantani A; Ciaschi V
    Eur Rev Med Pharmacol Sci; 2004; 8(6):289-94. PubMed ID: 15745389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternaria allergy: a three-year controlled study in children treated with immunotherapy.
    Cantani A; Businco E; Maglio A
    Allergol Immunopathol (Madr); 1988; 16(1):1-4. PubMed ID: 3381709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against allergies yields good symptom relief].
    Hedlin G; Arvidsson M
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1938-41. PubMed ID: 18681376
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters.
    Lizaso MT; Tabar AI; García BE; Gómez B; Algorta J; Asturias JA; Martínez A
    Pediatr Allergy Immunol; 2008 Feb; 19(1):76-81. PubMed ID: 17662037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evolution of patients with respiratory allergic disease due to sensitisation to Alternaria alternata being treated with subcutaneous immunotherapy.
    Zapatero L; Martínez-Cañavate A; Lucas JM; Guallar I; Torres J; Guardia P; Torre Fde L; Pedemonte C
    Allergol Immunopathol (Madr); 2011; 39(2):79-84. PubMed ID: 21236554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.
    Malling HJ; Bousquet J
    Clin Allergy Immunol; 2008; 21():343-58. PubMed ID: 18828516
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological standardization and maximum tolerated dose estimation of an Alternaria alternata allergenic extract.
    Lizaso MT; Martínez A; Asturias JA; Algorta J; Madariaga B; Labarta N; Tabar AI
    J Investig Allergol Clin Immunol; 2006; 16(2):94-103. PubMed ID: 16689182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.